WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (46)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hervé, D.
Right arrow Articles by Girault, J.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hervé, D.
Right arrow Articles by Girault, J.-A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*AMPHETAMINE
*CAFFEINE
*DOPAMINE

 Previous Article  |  Next Article 

The Journal of Neuroscience, June 15, 2001, 21(12):4390-4399

Galpha olf Levels Are Regulated by Receptor Usage and Control Dopamine and Adenosine Action in the Striatum

Denis Hervé1, Catherine Le Moine2, Jean-Christophe Corvol1, Leonardo Belluscio3, Catherine Ledent4, Allen A. Fienberg5, Mohamed Jaber6, Jeanne-Marie Studler1, and Jean-Antoine Girault1

1 Institut National de la Santé et de la Recherche Médicale (INSERM) U536, Institut du Fer à Moulin, 75005 Paris, France, 2 Centre National de la Recherche Scientifique Unité Mixte 5541, Laboratoire d'Histologie-Embryologie, Université Victor Segalen Bordeaux 2, 33076 Bordeaux cedex, France, 3 Department of Neurobiology, Duke University Medical Center, Durham, North Carolina 27710, 4 Institut de Recherche Interdisciplinaire en Biologie Humaine et Nucléaire, Université Libre de Bruxelles, Campus Erasme, B-1070 Bruxelles, Belgium, 5 Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, New York 10021, and 6 INSERM U259, Institut François Magendie, Université Bordeaux II, 33077 Bordeaux cedex, France


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

In the striatum, dopamine D1 and adenosine A2A receptors stimulate the production of cAMP, which is involved in neuromodulation and long-lasting changes in gene expression and synaptic function. Positive coupling of receptors to adenylyl cyclase can be mediated through the ubiquitous GTP-binding protein Galpha S subunit or through the olfactory isoform, Galpha olf, which predominates in the striatum. In this study, using double in situ hybridization, we show that virtually all striatal efferent neurons, identified by the expression of preproenkephalin A, substance P, or D1 receptor mRNA, contained high amounts of Galpha olf mRNA and undetectable levels of Galpha s mRNA. In contrast, the large cholinergic interneurons contained both Galpha olf and Galpha s transcripts. To assess the functional relationship between dopamine or adenosine receptors and G-proteins, we examined G-protein levels in the striatum of D1 and A2A receptor knock-out mice. A selective increase in Galpha olf protein was observed in these animals, without change in mRNA levels. Conversely, Galpha olf levels were decreased in animals lacking a functional dopamine transporter. These results indicate that Galpha olf protein levels are regulated through D1 and A2A receptor usage. To determine the functional consequences of changes in Galpha olf levels, we used heterozygous Galpha olf knock-out mice, which possess half of the normal Galpha olf levels. In these animals, the locomotor effects of amphetamine and caffeine, two psychostimulant drugs that affect dopamine and adenosine signaling, respectively, were markedly reduced. Together, these results identify Galpha olf as a critical and regulated component of both dopamine and adenosine signaling.

Key words: Golf; Gs; G-protein; D1 receptor; A2A receptor; knock-out mice; striatum; dopamine; adenosine; dopamine transporter; homologous recombination


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The nigrostriatal dopaminergic neurons are essential for proper motor function in both humans and rodents. In the dorsal striatum, dopaminergic influence is predominantly mediated through D1 (D1R) and D2 (D2R) dopamine receptors that stimulate and inhibit cAMP production, respectively (Sibley and Monsma, 1992; Jaber et al., 1996). cAMP signaling contributes largely to the acute effects of dopamine as well as to long-lasting changes in gene expression and synaptic plasticity (for review, see Greengard et al., 1999; Berke and Hyman, 2000). In the striatum, D1R and D2R are enriched in distinct populations of efferent GABAergic spiny neurons (Gerfen et al., 1990; Hersch et al., 1995; Le Moine and Bloch, 1995; Yung et al., 1996), although sensitive measurements reveal some degree of overlap in receptor distribution (Surmeier et al., 1996). The D1R-enriched population, referred to as striatonigral, projects to the substantia nigra pars reticulata and to the entopeduncular nucleus and contains substance P and dynorphin as cotransmitters, whereas the D2R-enriched population, referred to as striatopallidal, projects to the external globus pallidus and contains enkephalins (Beckstead and Cruz, 1986; Gerfen and Young, 1988; Gerfen et al., 1990; Le Moine et al., 1990, 1991; Le Moine and Bloch, 1995). In the striatopallidal neurons, which possess little or no D1R, adenosine A2A receptors (A2ARs) are the main receptor type stimulating the cAMP production (Premont et al., 1977; Schiffmann et al., 1991; Svenningsson et al., 1997). Because of this "strategic" location, A2ARs are potential therapeutic targets for treating psychosis and Parkinson's disease (Ledent et al., 1997; Svenningsson et al., 1999).

In spite of the strong effects of D1R and A2AR on cAMP production, the striatum contains small amounts of Galpha s, the G-protein subunit responsible for adenylyl cyclase stimulation in most cell types, but high concentrations of the olfactory isoform Galpha olf (Drinnan et al., 1991; Herve et al., 1993). Galpha olf shares 80% amino acid identity with Galpha s and mediates olfactory receptor signaling in the olfactory epithelium (Jones and Reed, 1989; Belluscio et al., 1998). Cocaine responses are abolished in Galpha olf knock-out mice, indicating that Galpha olf may be necessary for dopamine action (Zhuang et al., 2000), and recent data provide strong evidence that Galpha olf couples A2AR to adenylyl cyclase (Kull et al., 2000). Moreover, we have shown that D1R- and A2AR-stimulated cAMP production is blocked in the striatum of Galpha olf knock-out mice (Corvol et al., 2001).

The first aim of the present study was to characterize in detail the cellular localization of Galpha s and Galpha olf in the striatum using in situ hybridization. We then examined the functional relationship between striatal Galpha olf levels and dopamine or adenosine transmission, using mutant mice in which the genes for D1R, A2AR, or dopamine transporter (DAT) are disrupted. Finally, we examined the functional consequences of decreasing Galpha olf levels, by measuring the locomotor responses to amphetamine and caffeine in mice, which have reduced levels of Galpha olf. Our results indicate thus that Galpha olf is a crucial site for the regulation of D1R and A2AR efficacy in the striatum and a potential locus for dysfunction in dopamine and adenosine neurotransmission.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Tissue preparation for in situ hybridization. Brains from adult male Sprague Dawley rats (200-280 gm; Centre d'élevage Janvier, Le Genest. Saint-Isle, France) were dissected out, frozen in liquid nitrogen, and sectioned at the level of the striatum following the atlas of Swanson (1992) into 10-µm-thick sections that were stored at -80°C until use. All experiments were performed in accordance with the guidelines of the French Agriculture and Forestry Ministry for handling animals (decree 87849, license 01499) and with the Centre National de la Recherche Scientifique approval.

Probe synthesis. 35S-labeled or digoxigenin-labeled cRNA probes were prepared by in vitro transcription from rat or mouse (Galpha s) cDNA clones corresponding to fragments of Galpha olf, Galpha s, preproenkephalin A (Yoshikawa et al., 1984), substance P (Bonner et al., 1987), D1R (Monsma et al., 1990), and choline acetyltransferase (Ibanez et al., 1991) cDNAs. The Galpha olf cDNA clone corresponded to the clone 8 described by Herve et al. (1995), and the Galpha s cDNA clone corresponded to the most 3' 550 bp fragment of the murine Galpha s cDNA sequence (Sullivan et al., 1986). The sequence identity between Galpha olf and Galpha s probes was <30%. Transcription was performed from 50 ng of linearized plasmid using either 35S-UTP (>1000 Ci/mmol; NEN Life Science, Paris, France) or digoxigenin-11-UTP (Roche Diagnostic, Meylan, France) and SP6, T3, or T7 RNA polymerases as described (Le Moine and Bloch, 1995). After alkaline hydrolysis to obtain cRNA fragments of ~250 bp, the 35S-labeled probes were purified on Sephadex-G50. The 35S-labeled purified probes and the digoxigenin-labeled probes were precipitated in 3 M sodium acetate, pH 5, and absolute ethanol (0.1/2.5 vol).

In situ hybridization: single detection of Galpha olf and Galpha s mRNAs on cryostat sections. Cryostat sections were post-fixed in 4% paraformaldehyde (PFA) for 5 min at room temperature, rinsed twice in 4× SSC, and placed into 0.25% acetic anhydride with 0.1 M triethanolamine in 4× SSC, pH 8, for 10 min at room temperature. After dehydration, the sections were hybridized overnight at 55°C under coverslips with 106 cpm of 35S-labeled Galpha olf or Galpha s cRNA probes in 50 µl of hybridization solution (20 mM Tris-HCl, 1 mM EDTA, 300 mM NaCl, 50% formamide, 10% dextran sulfate, 1× Denhardt's reagent, 250 µg/ml yeast tRNA, 100 µg/ml salmon sperm DNA, 100 mM DTT, 0.1% SDS, and 0.1% sodium thiosulfate). Coverslips were removed by rinsing in 4× SSC. After 20 min of RNase A treatment (20 µg/ml) at 37°C, the sections were washed sequentially in 2× SSC (5 min, twice), 1× SSC (5 min), 0.5× SSC (5 min) at room temperature, and rinsed in 0.1× SSC at 65°C (30 min, twice) before dehydration (the latter SSC washes contained 1 mM DTT). Sections were used to expose x-ray films (Kodak Biomax; Eastman Kodak, Rochester, NY) for 3-6 d, and then dipped into Ilford K5 emulsion (diluted 1:3 in 1× SSC), which was developed after an 8 week exposition and stained with toluidine blue.

In situ hybridization: simultaneous detection of two mRNAs on the same sections. Different combinations of cRNA probes were used for the simultaneous detection of two mRNAs on the same sections. Cryostat sections were post-fixed, acetylated, and dehydrated as described above. Combinations of 35S- and digoxigenin-labeled probes (106 cpm of 35S-labeled probe plus 10-20 ng of digoxigenin-labeled probe) were hybridized in the same hybridization solution as described above. After elimination of coverslips, the slides were treated with RNase A and washed in decreasing concentrations of SSC as mentioned above, but without DTT. At the end of the washes, the slides were cooled in 0.1× SSC at room temperature and then processed directly for detection of the digoxigenin signal. The sections were rinsed twice for 5 min in buffer A (1 M NaCl, 0.1 M Tris, and 2 mM MgCl2, pH 7.5), and then for 30 min in buffer A containing 3% normal goat serum and 0.3% Triton X-100. After a 5 hr incubation at room temperature with alkaline phosphatase-conjugated anti-digoxigenin antiserum (1:1000 in buffer A containing 3% normal goat serum and 0.3% Triton X-100; Roche Diagnostic), the sections were rinsed twice 5 min in buffer A, twice 10 min in 1 M STM buffer (1 M NaCl, 0.1 M Tris, and 5 mM MgCl2, pH 9.5), and twice for 10 min in 0.1 M STM buffer (0.1 M NaCl, 0.1 M Tris, and 5 mM MgCl2, pH 9.5). The sections were then incubated overnight in the dark at room temperature in 0.1 M STM buffer containing 0.34 mg/ml nitroblue tetrazolium and 0.18 mg/ml bromo-chloro-indolylphosphate. The sections were rinsed briefly in 0.1 M STM buffer and 2 hr in 1× SSC, dried, and dipped into Ilford K5 emulsion (diluted 1:3 in 1× SSC). After being exposed 10-14 weeks in the dark, the emulsions were developed, and the sections were mounted without counterstaining. Labeled neurons both from single-labeling and double-labeling experiments were counted on sections from three different animals as previously described on similar material (Le Moine and Bloch, 1995).

Mutant mice. Pairs of heterozygous mice with a disrupted gene of Galpha olf (Belluscio et al., 1998) and a hybrid 129 and C57Bl/6 genetic background were crossed. The genomic DNA of the progeny was extracted from tail tissue, digested by HindIII, and hybridized with a Galpha olf probe corresponding 1.2 kb Pst/Kpn fragment of mouse Galpha olf gene located 0.5 kb upstream to the ATG codon translational start site. The probe hybridizes with fragments of 2.8 kb when the gene is mutated or 15 kb fragments in wild-type (Belluscio et al., 1998). Pairs of heterozygous mice bearing a null mutation for D1R or DAT gene and having a hybrid 129 and C57BL/6 genetic background were mated to obtain wild-type and homozygous mutant mice and were typed by Southern blot, as described by Drago et al. (1994) or by Giros et al. (1996). Male wild-type controls and homozygous A2AR (Ledent et al., 1997) or CB1 cannabinoid receptor (Ledent et al., 1999) knock-out mice used for the experiments were cousins, and their common grandparents were heterozygous mutant mice backcrossed on CD1 background for 10 generations. Mice were kept in stable conditions of temperature (22°C) and humidity (60%) with a constant cycle of 12 hr light and dark and had ad libitum access to food and water.

Galpha protein antibodies. Specific antibodies against Galpha olf (SL48SP) were obtained by immunizing a rabbit against a recombinant Galpha olf protein and by purifying the obtained serum with Galpha olf and Galpha s columns, as described previously (Corvol et al., 2001). Specific antibodies against Galpha s (SL22AP) were raised against a Galpha s-selective peptide and affinity-purified on a peptide column (Penit-Soria et al., 1997). The other antibodies were mouse monoclonal antibodies from commercial sources against Galpha o (clone L5.6; Neomarkers, Union City, CA), Galpha i2 (clone 2A.3; Neomarkers), and Gbeta (clone 3, Transduction Laboratories, Lexington, KY).

Immunoblot analysis. Wild-type and mutant mice (2-10 month old, age-matched) were killed by decapitation, and their brains were immediately dissected out from the skull and frozen on dry ice. Microdiscs of tissue were punched out from frozen slices (500-µm-thick) within the striatum using a stainless steel cylinder (1.4 mm diameter). Samples were homogenized in 1% SDS, equalized for their content in protein, and analyzed by Western blot as described previously (Herve et al., 1993). Antibody dilutions were 1:1000, 1:500, 1:300, 1:600, and 1:1000 for antibodies against Galpha olf, Galpha s, Galpha i2, Galpha o, and Gbeta , respectively. Antibodies were revealed by the peroxidase-chemiluminescence method (ECL; Amersham, Orsay, France) and autoradiography. The antibodies were stripped one or two times to detect other antigens on the same membranes (Erickson et al., 1982; Herve et al., 1993). Quantification was performed by optical density measurement on autoradiographic films using a computer-assisted densitometer and the NIH Image software. In each membrane, samples from control and mutant mice were alternatively loaded, and the results were normalized as percentage of the mean of controls in each membrane.

cDNA probes and Northern analysis. The Galpha olf cDNA probe corresponded to a PCR fragment containing the 1156 bp of the coding region of rat cDNA clone (Jones and Reed, 1989; Herve et al., 1995) and the Galpha s probe was the same as described above. The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe was a 1.3 kbp full length of rat GAPDH cDNA (Fort et al., 1985). Total RNA was extracted by the guanidinium thiocyanate-phenol-chloroform method (Chomczynski and Sacchi, 1987) from tissue microdiscs taken on frozen slices, and Northern blots were generated as previously described (Herve et al., 1993). The filters were hybridized successively with Galpha olf, Galpha s, and GAPDH probes, with a dehybridation step between two hybridations consisting in the incubation of membrane in boiling 0.5% SDS. Radioactivity of positive bands was measured using Instant Imager (Packard, Downers Groves, IL). Galpha olf and Galpha s mRNA concentrations were expressed as the counts per minute ratio of Galpha olf/GAPDH and Galpha s/GAPDH, respectively.

(3H)SCH23390, (125I)iodosulpride, (3H)CGS21680, and (3H)WIN35428 binding. Twenty micrometer coronal brain sections from three adult heterozygous Galpha olf +/- mice and three wild-type littermates were thaw-mounted onto SuperFrost microscope slides. D1R, D2R, A2AR, and DATs were analyzed by incubating the tissue sections with 2.5 nM (3H)SCH23390 (91 Ci/mmol), 0.2 nM (125I)iodosulpride (2000 Ci/mmol), 5 nM (3H)CGS21680 (47 Ci/mmol,) and 4 nM (3H)WIN35428 (86 Ci/mmol), respectively, in conditions as previously described (Bouthenet et al., 1987; Savasta et al., 1988; Jarvis and Williams, 1989; Herbert et al., 1999). The radioligands were obtained from Amersham Pharmacia Biotech (Saclay, France) or from NEN (Boston, MA). Nonspecific binding was determined from adjacent brain sections in the presence of 1 µM SCH23390, 10 µM sulpiride, 10 µM CGS21680, and 30 µM benztropine for blocking D1R, D2R, A2AR, and DATs, respectively. After washing in ice-cold buffer, brain sections were rapidly dried and used to expose tritium-sensitive film (Hyperfilm 3H; Amersham). In autoradiographs, the binding in caudate putamen and nucleus accumbens was evaluated by measuring the optical density with a computer-assisted image analyzer and the NIH image software, and the data were expressed in femtomoles of bound ligand per milligram of tissue using standards (3H-microscales; Amersham Pharmacia Biotech).

Locomotor activity. Male heterozygous Galpha olf +/- mice and wild-type littermates were introduced in a circular corridor (4.5 cm width, 17 cm external diameter) crossed by four infrared beams (1.5 cm above the base) placed at every 90° (Imetronic, Pessac, France). The locomotion was counted when the animals interrupted two successive beams and, thus, had traveled one-fourth of the circular corridor. In each session, the spontaneous activity was recorded for 50 min, before the animals were injected with saline or drugs, and their activity was recorded for an additional 60 or 120 min period. In the two first sessions, the animals received saline injections (5 ml/kg, i.p.), and in the third session, they received amphetamine (1, 2, or 3 mg/kg, i.p) or caffeine (25 mg/kg, i.p.) dissolved in saline. For each session an equal number of heterozygous and wild-type mice was studied, and for each drug treatment, groups of 7-14 animals were compared. The tests were performed between 12:00 and 6:00 P.M. in stable conditions of temperature and humidity.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Characterization of striatal neurons expressing Galpha s and Galpha olf mRNAs

As previously reported (Drinnan et al., 1991; Herve et al., 1993; Kull et al., 2000), the striatum was the brain region in which the contrast between the levels of Galpha s and Galpha olf mRNAs was the most dramatic (Fig. 1). At low magnification, high levels of Galpha olf mRNAs were observed in all the striatal areas, including caudate putamen (Cp), nucleus accumbens (NA), and olfactory tubercle (OT) (Fig. 1A,C,E,G), which appeared almost devoid of Galpha s mRNAs (Fig. 1D,F). A strong signal for both Galpha olf and Galpha s was detected in a few regions, including piriform cortex (Pir), islands of Calleja, medial habenula (Hb), and dentate gyrus (DG) (Fig. 1A-H), whereas in most other brain areas an intense labeling for Galpha s mRNAs was associated with low or no labeling for Galpha olf mRNA (Fig. 1A-H). The use of sense probes showed no labeling for either Galpha olf (Fig. 1I) or Galpha s (Fig. 1J) mRNAs.



View larger version (72K):
[in this window]
[in a new window]
 
Figure 1.   Distribution of Galpha olf and Galpha s mRNAs in forebrain. Negative of x-ray films exposed to rat brain adjacent sections hybridized with 35S-labeled probes for Galpha olf and Galpha s mRNAs. A, C, E, G, Galpha olf mRNA was highly expressed in striatal areas, including caudate putamen, nucleus accumbens, and olfactory tubercle (C, E, G). A signal was also found in the piriform cortex, the islands of Calleja, the medial habenula, and the dentate gyrus (A, C, E, G). All the other areas showed very low or no labeling for Galpha olf mRNA. B, D, F, H, On the contrary, Galpha s mRNA was highly expressed in many brain areas including all cortical areas, septum, globus pallidus, most of the hypothalamic and thalamic nuclei, hippocampus, and amygdala (B, D, F, H). Caudate putamen, nucleus accumbens, and olfactory tubercles showed almost no labeling, except for some sparse neurons (D, F). A total absence of labeling was observed in control experiments using sense probes for Galpha olf and Galpha s mRNAs (I, J). Cp, Caudate putamen; NA, nucleus accumbens; OT, olfactory tubercle; GP, globus pallidus; Hb, medial habenula; DG, dentate gyrus; Pir, piriform cortex. Scale bar, 5 mm.

At the cellular level Galpha olf mRNA was expressed in 96.5 ± 1.3% (n = 1250) of the striatal neurons, mostly medium-sized. Conversely, Galpha s mRNA-positive neurons were scattered all over the striatal areas, including 13.4 ± 1.2% (n = 1300) of the caudate putamen neurons, from which approximately one-third were large-sized. Double-labeling experiments were performed using various combinations of Galpha olf and Galpha s probes labeled with 35S or digoxigenin. Virtually all Galpha s mRNA-positive neurons expressed Galpha olf mRNA levels above background, whereas Galpha olf mRNA was present in numerous neurons with no labeling for Galpha s mRNA (Fig. 2A,B). In particular, Galpha olf mRNA was present in almost all striatal medium-sized neurons, very few of which also expressed high levels of Galpha s mRNA (Fig. 2B, arrow). Simultaneous detection of Galpha olf mRNA and D1R mRNA showed that virtually all cells expressing D1R mRNA were positive for Galpha olf mRNA (Fig. 2C, arrows). However, approximately half of Galpha olf-positive neurons did not contain D1R mRNA (Fig. 2C, white arrowheads). Large-sized neurons were positive for both Galpha olf and Galpha s (Fig. 2B, arrowhead). These large neurons, which contained Galpha olf mRNA, as well as Galpha s mRNA, were cholinergic interneurons, as demonstrated with a digoxigenin-labeled probe for choline acetyltransferase mRNA (Fig. 2D,E, arrows).



View larger version (129K):
[in this window]
[in a new window]
 
Figure 2.   Phenotypical characterization of striatal neurons expressing Galpha olf and Galpha s mRNAs. Double-labeling in situ hybridization of rat brain sections was performed with various combinations of 35S-labeled probes (indicated by asterisks in the figure) and digoxigenin-labeled probes. In all photomicrographs, silver grains for 35S-labeling are visualized using epi-illumination and appear as bright yellow grains, whereas digoxigenin labeling appears as purple staining. A, Most Galpha olf-positive neurons (silver grains) did not contain Galpha s mRNA (digoxigenin), which was present in only a few large- or medium-sized neurons (which also contained Galpha olf mRNA; 35S, arrows). B, The reverse combination of probe labeling showed that Galpha olf mRNA (digoxigenin) was present in numerous medium-sized neurons, few of which also expressed significant levels of Galpha s mRNA (35S, arrow). Most of the large-sized neurons contained both mRNAs (arrowhead). C, Simultaneous detection of Galpha olf mRNA (digoxigenin) and D1R mRNA (silver grains) showed that Galpha olf mRNA was colocalized with D1R mRNA (arrows), but approximately half of Galpha olf mRNA-positive neurons did not contain D1R mRNA (white arrowheads). D, E, Double labeling for choline acetyltransferase mRNA (digoxigenin) and Galpha olf mRNA (35S; D) or Galpha s mRNA (35S; E). Both Galpha olf and Galpha s mRNAs were present in choline acetyltransferase-positive large neurons (arrows). Numerous medium-sized neurons expressed only Galpha olf mRNA (D, white arrowhead), whereas very few expressed Galpha s mRNA (E, white arrowhead). F, G, Double labeling for PPA (digoxigenin) and Galpha olf mRNA (35S; F) or Galpha s mRNA (35S; G). H, I, Double labeling for substance P mRNA (SP; digoxigenin) and Galpha olf mRNA (35S; H) or Galpha s mRNA (35S; I). Galpha olf mRNA was present both in preproenkephalin A-positive (F, arrows) and substance P-positive (H, arrows) neurons, as well as in negative cells (F, H, silver grains). Galpha s mRNA was mainly absent in these digoxigenin-labeled neurons (G, I, arrows). Scale bar, 12 µm.

In the dorsal striatum, the striatopallidal and striatonigral medium-sized spiny neurons were identified using digoxigenin-labeled probes for preproenkephalin A mRNA (PPA) (Fig. 2F,G) or for substance P mRNA (SP) (Fig. 2H,I), respectively. Galpha olf mRNA (35S-labeled probe) was present in both preproenkephalin A- and substance P mRNA-containing neurons (Fig. 2F,H, arrows), whereas the levels of silver grains for Galpha s mRNA (35S-labeled probe) in these neurons were close to background (Fig. 2G,I, arrows).

Alterations of striatal G-protein levels in mice lacking D1 receptors

Previous studies had shown that destruction of dopamine neurons resulted in an increase in Galpha olf protein levels (Herve et al., 1993; Marcotte et al., 1994; Penit-Soria et al., 1997). The simplest explanation of these observations was that the increase in Galpha olf was the consequence of the chronic absence of dopamine receptor stimulation. We therefore examined whether the complete absence of D1R was able to alter Galpha olf, using mice in which the D1R gene had been disrupted (Drago et al., 1994). As shown in Figure 3, the striatal Galpha olf concentrations were higher in mutant mice than in wild-type littermates, whereas the levels of other G-protein alpha  subunits Galpha s, Galpha o, and Galpha i2 were not altered (Fig. 3A,B). The levels of Gbeta subunit were also significantly increased in D1R knock-out animals (Fig. 3A,B), probably reflecting the stoichiometric increase in Gbeta subunits participating in heterotrimeric complexes with Galpha olf. The lower increase in Gbeta (+36 ± 5%) than in Galpha olf (+80 ± 10%) levels can be accounted for by the association of Gbeta subunits with other alpha  subunits, which remained unaffected. Interestingly, a slight but significant increase in Galpha olf protein was also detected in the striatum of heterozygous animals having only one null allele for the D1R gene (116 ± 5% of wild-type; n = 15; p < 0.05), whereas Galpha s protein levels were unchanged in these animals (103 ± 5% of controls).



View larger version (22K):
[in this window]
[in a new window]
 
Figure 3.   Levels of G-proteins in the striatum of D1 receptor knock-out mice. A, Western blot analysis of representative striatal homogenates from D1R knock-out (D1R -/-) mice or wild-type controls (D1R +/+), with antibodies that recognize specifically Galpha olf, Galpha s, Galpha i2, and Gbeta . B, The optical density of immunoreactive bands was quantified on films and normalized taking as 100% of the mean optical density of controls on each film (see Materials and Methods). Results correspond to the mean ± SEM of data obtained in 6-16 animals studied in three independent experiments. *p < 0.05 and **p < 0.01 by two-tailed Student's t test. C, Northern analysis of RNA isolated from the striata of D1R knock-out (D1R -/-) mice and wild-type control (D1R +/+) mice. In each lane, the amounts of 32P-labeled Galpha olf, Galpha s, and GAPDH probes bound to the membranes were measured with an Instant Imager. The levels of Galpha olf and Galpha s mRNA were normalized to those of GAPDH mRNA and were expressed as a percentage of mean value measured in wild-type controls (n = 14-16).

We examined Galpha olf mRNA levels by Northern blot to determine whether the increase in Galpha olf protein observed in the striatum of mutant mice resulted from an increase in the transcription of the Galpha olf gene and/or a stabilization of its transcript (Fig. 3C). At least two species of Galpha olf mRNA were detected in the striatum of wild-type and mutant mice resulting from variations in the length of 5'- and 3'-untranslated regions of Galpha olf mRNAs, as described previously (Herve et al., 1995). When we measured the total amount of radioactive probe hybridized with all the Galpha olf mRNA species in Northern blots, the concentration of Galpha olf transcripts was not significantly different in the striatum of D1R -/- mutant mice or wild-type mice (Fig. 3C). When radioactivity was measured independently for the two main bands, no significant variation was observed in the striatum of D1R-deficient mice, suggesting that the size pattern of Galpha olf mRNA was unaffected in these mice (data not shown). Thus, the increase in Galpha olf protein observed in the striatum of D1R -/- mutant mice was not the consequence of alterations in Galpha olf mRNA levels. Galpha s mRNA concentrations were also not significantly altered in the striatum of D1R knock-out mice (Fig. 3C).

Alterations of striatal Galpha olf protein levels in mice lacking dopamine transporter

The results obtained in D1R-deficient mice, as well as previous experiments using dopamine-depleted animals, indicated that an impairment in dopamine transmission could increase the levels of Galpha olf in the striatum. To test if constitutive upregulation of dopamine neurotransmission could affect Galpha olf in the opposite direction, we examined the striatal concentrations of Galpha olf in mutant mice lacking DAT, responsible for the largest part of dopamine clearance from the extracellular space (Giros et al., 1996). The levels of Galpha olf, but not Galpha s, were decreased in the striatum of these mice (Fig. 4). Thus, the chronic increase in the stimulation of D1R on the one hand, and the absence of D1R or of dopamine stimulation on the other hand, altered Galpha olf protein levels in opposite directions.



View larger version (37K):
[in this window]
[in a new window]
 
Figure 4.   Levels of Galpha olf and Galpha s proteins in the striatum of dopamine transporter knock-out mice. A, Western blot analysis of representative striatal homogenates from DAT knock-out mice (DAT-/-) or wild-type littermates (DAT +/+). Blots were incubated with antibodies that recognize specifically Galpha olf or Galpha s. B, The optical density of immunoreactive bands was quantified on films as in Figure 3B (n = 8; *p < 0.02; two-tailed Student's t test).

Alterations of striatal Galpha olf protein levels in mice lacking A2A receptors

Because Galpha olf was expressed in neurons containing A2AR and because the lack of Galpha olf abolished the cAMP production induced by an A2 agonist (Corvol et al., 2001), we examined whether the absence of A2AR could alter Galpha olf levels in a manner similar to D1R. To evaluate this possibility, we measured Galpha olf protein and other G-protein subunits in the striatum of mutant mice lacking A2AR (Ledent et al., 1997). By comparison to wild-type controls, an increase in Galpha olf protein levels was observed in A2AR knock-out mice, whereas Galpha s, Galpha o, and Galpha i2 subunits were not significantly altered in the same striatal samples (Fig. 5A,B). In contrast to what was seen in D1R knock-out mice, no change in striatal concentrations of Gbeta was detected in A2AR knock-out mice (Fig. 5B). This may be attributable to the fact that the increase in the concentration of Galpha olf was less pronounced than in D1R -/- mice, and not sufficient to enhance significantly the total levels of Gbeta . As in the case of D1R, the total amounts of Galpha olf and Galpha s mRNA (Fig. 5C) and the expression pattern of the various forms of Galpha olf mRNA (data not shown) were not altered in A2AR knock-out mice.



View larger version (23K):
[in this window]
[in a new window]
 
Figure 5.   Levels of G-proteins in striatum of A2A receptor knock-out mice. A, Western blot analysis of representative striatal homogenates from A2AR knock-out mice (A2AR -/-) or wild-type controls (A2AR +/+), with antibodies that recognize specifically Galpha olf, Galpha s, and Galpha o. B, The optical density of immunoreactive bands was quantified on films as in Figure 3B (n = 4-7; *p < 0.01; two-tailed Student's t test). C, Northern analysis of RNA isolated from the striata of A2AR knock-out (A2AR -/-) mice and wild-type control (A2AR +/+) mice. Results were obtained as described in the legend to C (n = 10-11).

The observed increases in Galpha olf protein levels seen in D1R and A2AR knock-out mice could be an unspecific consequence of the absence of any G-protein-coupled receptor. To rule out this possibility, we measured the G-protein subunits levels in knock-out mice lacking CB1 cannabinoid receptors, which are expressed at very high levels in medium-sized spiny neurons, but are negatively coupled to adenylyl cyclase unlike the D1R and A2AR (Ledent et al., 1999). The lack of expression of CB1 receptors in the striatum induced no significant modification in the striatal concentrations of Galpha olf (93 ± 5% of wild-type; n = 4). The striatal levels of Galpha s, Galpha o, Galpha i1, Galpha i2, and Gbeta subunits were also unchanged in these mice (data not shown). It is noteworthy that the deficiency in functional D2R was reported to have no influence on Galpha olf mRNA expression in the striatum (Zahniser et al., 2000).

Locomotor responses to amphetamine and caffeine in mice heterozygous for a null mutation of Galpha olf

Because alterations of dopamine or adenosine transmission affected Galpha olf levels, we investigated whether changes in G-protein levels could have functional consequences on behavioral responses mediated through D1R and A2AR. In the striatum of mice heterozygous for a null mutation of Galpha olf gene (Galpha olf +/-), the levels of Galpha olf were approximately half of those in wild-type mice, and the D1R- and A2AR-stimulated adenylyl cyclase responses were significantly reduced (Corvol et al., 2001). Thus, these mice provided an excellent model to test the effects of reduced amounts of Galpha olf, such as those observed in DAT-deficient mice, without the interference of other alterations of dopamine neurotransmission.

We examined the locomotor activity of Galpha olf +/- mice and wild-type littermates in response to D-amphetamine and caffeine, two drugs whose actions depend on D1R and A2AR, respectively (Crawford et al., 1997; Ledent et al., 1997). The locomotor activity of mice was tested in three sessions, in which their basal activity was first monitored (Fig. 6A). During the second and third sessions, Galpha olf +/- mice had a slightly lower spontaneous activity than wild-type littermates (Fig. 6A). The response to drugs was studied during the third session. When Galpha olf +/- mice were challenged with 1, 2, or 3 mg/kg of D-amphetamine (Fig. 6B) or with 25 mg/kg of caffeine (Fig. 6C), their locomotor activity was stimulated but remained significantly lower than that of wild-type mice receiving the same treatments (Fig. 6B,C). Interestingly, the slight increase in locomotor activity induced by saline injection was also decreased in Galpha olf +/- mice (Fig. 6B).



View larger version (20K):
[in this window]
[in a new window]
 
Figure 6.   Effects of amphetamine and caffeine on the locomotor activity of Galpha olf +/- mice. The horizontal activity of male heterozygous (Galpha olf +/-) and wild-type (Galpha olf +/+) mice was measured in three sessions. In each session, animals were allowed to habituate to the testing apparatus for 50 min and received saline injections in the two first sessions and amphetamine (1, 2, or 3 mg/kg) or caffeine (25 mg/kg) in the third session. A, Spontaneous activity of Galpha olf +/- and Galpha olf +/+ mice during the 50 min habituation period in the three sessions. Activities were significantly lower in mutant mice during sessions 2 and 3 (two-way ANOVA; F(1,260) = 22.3 and F(1,260) = 33.1, respectively; p < 0.001). B, Effects of amphetamine or saline injections on the locomotor activity of Galpha olf +/- mice. Data for saline correspond to the results obtained in the second session. C, Effects of caffeine on the locomotor activity of Galpha olf +/- mice. The results are the mean ± SEM of data obtained with 7-14 animals. *p < 0.05 and **p < 0.01, significantly different from wild-type controls with the same treatment.

In Galpha olf +/- mice, the alterations in responses to amphetamine and caffeine were not caused by changes in D1R, D2R, or A2AR levels in the caudate putamen or nucleus accumbens because the binding of (3H)SCH23390, (125I)iodosulpride, and (3H)CGS21680 was unchanged in these brain regions (Fig. 7). The measurements of the (3H)WIN35428 binding in the caudate putamen and nucleus accumbens of Galpha olf +/- mice (Fig. 7) indicated also a normal density of DAT, which is known to be crucial for the psychostimulant effect of D-amphetamine in mouse (Giros et al., 1996).



View larger version (65K):
[in this window]
[in a new window]
 
Figure 7.   Lack of change in D1, D2, and A2A receptors and in dopamine transporter in the caudate putamen and nucleus accumbens of heterozygous Galpha olf knock-out mice. Coronal brain sections at the level of the striatum were incubated with (3H)SCH23390, (125I)iodosulpride, (3H)CGS21680, or (3H)WIN35428 to analyze the D1R, D2R, A2AR, and DAT, respectively. The optical densities in the caudate putamen and the nucleus accumbens were measured in at least six different sections in each mouse and compared with standards. The results correspond to the mean ± SEM of data obtained in three mutant mice and three wild-type littermates. Scale bar, 5 mm.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Neuronal expression of Galpha olf and Galpha s in the striatum

Receptor-regulated production of cAMP in the striatum plays a central role in the physiology of the basal ganglia as well as in the long-term modifications that take place after repeated administration of drugs of abuse (for review, see Greengard et al., 1999; Berke and Hyman, 2000). The striatum contains high levels of Galpha olf and very low levels of Galpha s (Drinnan et al., 1991; Herve et al., 1993). Recent studies have demonstrated the role of Galpha olf in receptor-regulated cAMP production of the striatum and its functional consequences (Zhuang et al., 2000; Corvol et al., 2001). We confirm here that most medium-sized neurons, which correspond to GABAergic output spiny neurons and represent the vast majority of striatal neurons (Kemp and Powell, 1971), express Galpha olf and very little or no Galpha s transcripts (Kull et al., 2000). In the rat dorsal striatum these output neurons are divided in two populations identified on the basis of the neuropeptides they express (Gerfen and Young, 1988). We found that Galpha olf mRNA was expressed in both types of neurons, which did not contain significant amounts of Galpha s mRNA. Moreover, D1R-positive neurons expressed Galpha olf transcripts, but no detectable Galpha s. The rare medium-sized neurons containing Galpha s mRNA also expressed Galpha olf in double-labeling experiments. Because substance P- or preproenkephalin A-positive neurons did not express Galpha s, the medium-sized neurons containing both Galpha s and Galpha olf mRNA are likely to be aspiny interneurons (Kawaguchi et al., 1995). Interestingly, we show here that large-sized cholinergic interneurons, identified by the presence of choline acetyltransferase mRNAs, expressed both Galpha olf and Galpha s mRNAs. Striatal cholinergic neurons contain no A2AR (Svenningsson et al., 1997), but a few express low amounts of D1R (Le Moine et al., 1991; Surmeier et al., 1996). Recent experiments using in situ hybridization have also confirmed the presence of D5 receptor mRNA in these neurons (C. Le Moine, unpublished data), as previously indicated by single-cell RT-PCR experiments (Yan and Surmeier, 1997) and an immunohistochemical study in primate (Bergson et al., 1995). Our results indicate that both Galpha olf and Galpha s may couple D1R and D5 receptors to adenylyl cyclase in striatal cholinergic neurons. Thus, it appears that virtually all the striatal output neurons express only Galpha olf, whereas interneurons express both Galpha olf and Galpha s. The presence of Galpha olf transcripts, but not of Galpha s, in D1R- and A2AR-rich output neurons, accounts for the fact that cAMP formation by stimulation of these receptors was virtually abolished in Galpha olf mutant mice (Corvol et al., 2001).

Regulation of Galpha olf levels in mice with genetically altered D1 or A2A signaling

In a previous study we have shown that the disappearance of striatal dopamine increased Galpha olf levels by 40-50% (Herve et al., 1993; Penit-Soria et al., 1997). In mutant mice lacking either D1R or A2AR we found a selective increase in Galpha olf protein. Together these observations reveal that a lack of stimulation of D1R, as well as the absence of either D1R or A2AR, result in an upregulation of Galpha olf levels, suggesting that receptor usage may control Galpha olf levels. This hypothesis is corroborated by the study of DAT -/- mice, which provide a model of chronic hyperstimulation of dopamine receptors in vivo (Giros et al., 1996). In these mice the levels of Galpha olf protein were decreased in the striatum. These variations are reminiscent, at the level of a G-protein, of the classical "denervation hypersensitivity" and "agonist-induced desensitization," well characterized at the level of receptors (Freedman and Lefkowitz, 1996; Bloch et al., 1999).

Our results show that in A2AR and D1R mutant mice, the changes in Galpha olf occur at a post-transcriptional level and do not result from a change in gene expression. Preliminary evidence suggests that regulation of Galpha olf levels may also be independent of cAMP-regulated protein phosphorylation pathways, because these levels were unchanged in mice lacking functional DARPP-32 (D. Herve, A. Fienberg, and J. A. Girault, unpublished observations), a key mediator in striatal cAMP-dependent protein phosphorylation (Fienberg et al., 1998). A more attractive possibility is that alterations in Galpha olf protein levels result directly from changes in its rate of activation. This hypothesis is supported by several cell culture studies on Galpha s. In NG108-15 cells, stimulation of receptors activating adenylyl cyclase induced a downregulation of Galpha s at a post-translational level, which was independent of cAMP production (McKenzie and Milligan, 1990; Adie and Milligan, 1994). Similarly, strong activation of Galpha s by cholera toxin or by an activating mutation dramatically decreased its cellular concentration, possibly by an increased degradation (Levis and Bourne, 1992; Milligan, 1993). We suggest that analogous changes in Galpha olf degradation rate may account for the changes in its levels observed here in vivo. Normal stimulation of D1R and A2AR by endogenous dopamine and adenosine would result in a basal rate of Galpha olf degradation, which is reduced in mice lacking dopamine or functional D1R or A2AR. Conversely, in mice lacking DAT, overstimulation of D1R would increase Galpha olf rate of degradation. According to this hypothesis, the changes in Galpha olf concentration are expected to occur only in the striatal cells affected by the mutation, i.e., striatonigral cells in mice lacking functional D1R or DAT or striatopallidal cells in mice lacking functional A2AR.

Role of Galpha olf in locomotor activity

We have recently shown that reduced levels of Galpha olf in heterozygous mutant mice (Galpha olf +/-) resulted in a reduced stimulation of adenylyl cyclase by D1R and A2AR in the striatum (Corvol et al., 2001). The present study demonstrates that reduced availability of Galpha olf in these mice has also important functional consequences on spontaneous and drug-stimulated locomotor activity, revealing a novel phenotype of haplo-insufficiency.

The ventral striatum, including the nucleus accumbens, is involved in spontaneous and drug-stimulated motor activity (Pennartz et al., 1994). A role for D1R in the control of locomotor activity is supported by several studies. Microinjection of D1R antagonist in the ventral striatum of rats reduces their locomotor activity, whereas D1R agonists have the opposite effect (Meyer, 1993). Accordingly, the decreased coupling of D1R to adenylyl cyclase in the ventral striatum of Galpha olf +/- mice could account for their slightly lower locomotor activity. By contrast it should be noted that an increase in basal activity has been reported in Galpha olf -/- mice (Belluscio et al., 1998; Zhuang et al., 2000) and D1R -/- mice (Xu et al., 1994). These surprising observations contrasted with the pharmacological evidence for a stimulatory role on motor activity of D1R in the nucleus accumbens (Meyer, 1993; Vezina et al., 1994). These paradoxical behavioral effects in Galpha olf -/- and D1R -/- mice could be caused by differences in the methods used for measuring locomotor activity or alternatively may be the consequences of developmental changes and/or compensatory actions of other neuromodulatory systems such as serotoninergic or noradrenergic systems (Tassin et al., 1992; Trovero et al., 1992; Gainetdinov et al., 1999). Nevertheless, in both Galpha olf -/- and D1R -/- mice, the locomotor responses to cocaine or amphetamine are lost, unambiguously showing that both Galpha olf and D1R are necessary for the locomotor responses induced by these psychostimulants (Xu et al., 1994; Crawford et al., 1997; Zhuang et al., 2000). Interestingly, the acute effects of D-amphetamine on motor activity diminished in Galpha olf +/- mice, further demonstrating that Galpha olf levels determine the amplitude of D1R-mediated responses.

In Galpha olf +/- mice, the effects of caffeine on motor activity were reduced, indicating that Galpha olf levels are an important factor for caffeine-induced behavioral response. The psychostimulant effects of caffeine are mediated through A2AR and are absent in mutant mice lacking these receptors (El Yacoubi et al., 2000). Caffeine is a nonselective antagonist of A2AR, and caffeine could have a reduced effect in Galpha olf +/- mice because the ongoing A2AR signaling, which is produced by endogenous adenosine, is blunted in these mice. This explanation is likely because endogenous levels of adenosine are sufficient to cause the activation of adenosine receptors in brain (for review, see Svenningsson et al., 1999). However, D1R activity is required for caffeine-induced motor effect (Garrett and Holtzman, 1994), and the lower D1R signaling in Galpha olf +/- mice could also contribute to the attenuation of caffeine effects. Further experiments are needed to explore the respective contribution of these two mechanisms, both leading to a diminished effect of caffeine.

Functional implications

The present study demonstrates that experimental alterations in Galpha olf concentrations affect two important types of neurotransmission in basal ganglia and provides strong evidence that Galpha olf levels in striatal neurons are regulated in vivo by its use. Whereas much effort has been devoted to understand desensitization and downregulation of G-protein-coupled receptors in vitro and in vivo (Freedman and Lefkowitz, 1996; Bloch et al., 1999), little is known about the regulations that take place at the level of G-proteins. Our previous results in 6-hydroxydopamine-lesioned rats, as well as the present results in mice with genetically altered neurotransmission, show that a loss of D1R activation or the absence of D1R or A2AR result in an upregulation of Galpha olf. Thus, Galpha olf constitutes an attractive locus for the regulation of D1R and A2AR signaling in the striatum, either by modulation of its levels, or, possibly, by functionally relevant post-translational modifications. Alterations in Galpha olf levels and/or activity are parameters that will have to be carefully considered in the function of the basal ganglia in physiological and pathological conditions. In this respect, our results introduce Galpha olf heterozygous mutant mice as a potential animal model for studying striatum-dependent behavioral dysfunctions.


    FOOTNOTES

Received Jan. 29, 2001; revised March 20, 2001; accepted March 27, 2001.

This work has been supported by Institut National de la Santé et de la Recherche Médicale, by a grant from Mission Interministérielle de lutte contre la Drogue et la Toxicomanie addiction program, and by Grant 97H0003 from Ministère de Education Nationale de l'Enseignement Supérieur et de la Recherche. We thank F. Laujay for his help with in situ hybridization experiments, R. Axel, J. Drago, M. Parmentier, B. Giros, and M. Caron for kindly allowing the use of Galpha olf, D1R, A2AR, and DAT mutant mice, respectively, F. Gonon and E. Borrelli for providing us with some mutant mice, P. Ingrassia, R. Urbe, and H. Ibrahim for their help with animal breeding, and C. Drouin and J. P. Tassin for their advice about the measure of locomotor activity. We thank J. Glowinski and his colleagues of INSERM U114 for their support.

Correspondence should be addressed to D. Hervé, INSERM U536, Collège de France, 11, place Marcelin Berthelot, 75231 Paris, France. E-mail: denis.herve{at}infobiogen.fr.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

  • Adie EJ, Milligan G (1994) Agonist regulation of cellular Gs alpha-subunit levels in neuroblastoma x glioma hybrid NG108-15 cells transfected to express different levels of the human beta 2 adrenoceptor. Biochem J 300:709-715.
  • Beckstead RM, Cruz CJ (1986) Striatal axons to the globus pallidus, entopeduncular nucleus and substantia nigra come mainly from separate cell populations in cat. Neuroscience 19:147-158[Web of Science][Medline].
  • Belluscio L, Gold GH, Nemes A, Axel R (1998) Mice deficient in Golf are anosmic. Neuron 20:69-81[Web of Science][Medline].
  • Bergson C, Mrzljak L, Smiley JF, Pappy M, Levenson R, Goldman-Rakic PS (1995) Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J Neurosci 15:7821-7836[Abstract].
  • Berke JD, Hyman SE (2000) Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25:515-532[Web of Science][Medline].
  • Bloch B, Dumartin B, Bernard V (1999) In vivo regulation of intraneuronal trafficking of G-protein-coupled receptors for neurotransmitters. Trends Pharmacol Sci 20:315-319[Medline].
  • Bonner TI, Affolter HU, Young AC, Young WS (1987) A cDNA encoding the precursor of the rat neuropeptide, neurokinin B. Brain Res 388:243-249[Medline].
  • Bouthenet ML, Martres MP, Sales N, Schwartz JC (1987) A detailed mapping of dopamine D2 receptors in rat central nervous system by autoradiography with (125I)iodosulpride. Neuroscience 20:117-155[Web of Science][Medline].
  • Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium-phenol-chloroform extraction. Anal Biochem 162:156-159[Web of Science][Medline].
  • Corvol J-C, Studler J-M, Schonn J-S, Girault J-A, Hervé D (2001) Galpha olf is necessary for coupling D1 and A2 receptors to adenylyl cyclase in the striatum. J Neurochem 76:1585-1588[Web of Science][Medline].
  • Crawford CA, Drago J, Watson JB, Levine MS (1997) Effect of repeated amphetamine treatment on the locomotor activity of dopamine D1a-deficient mouse. NeuroReport 8:2523-2527[Web of Science][Medline].
  • Drago J, Gerfen CR, Lachowicz JE, Steiner H, Hollon TR, Love PE, Ooi GT, Grinberg A, Lee EJ, SP H, Bartlett PF, Jose PA, Sibley DR, Westphal H (1994) Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proc Natl Acad Sci USA 91:12564-12568[Abstract/Free Full Text].
  • Drinnan SL, Hope BP, Snutch TP, Vincent SR (1991) Golf in the basal ganglia. Mol Cell Neurosci 2:66-70.
  • El Yacoubi M, Ledent C, Ménard J-F, Parmentier M, Costentin J, Vaugeois J-M (2000) The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A2A receptors. Br J Pharmacol 129:1465-1473[Web of Science][Medline].
  • Erickson PF, Minier LN, Lasher RS (1982) Quantitative electrophoretic transfer of polypeptides from SDS polyacrylamine gels to nitrocellulose sheets: a method for their re-use in immunoautoradiographic detection of antigens. J Immunol Methods 51:241-249[Web of Science][Medline].
  • Fienberg AA, Hiroi N, Mermelstein PG, Song W, Snyder GL, Nishi A, Cheramy A, O'Callaghan JP, Miller DB, Cole DG, Corbett R, Haile CN, Cooper DC, Onn SP, Grace AA, Ouimet CC, White FJ, Hyman SE, Surmeier DJ, Girault J, Nestler EJ, Greengard P (1998) DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281:838-842[Abstract/Free Full Text].
  • Fort P, Marty L, Piechaczyk M, El Sabrouty S, Dani C, Jeanteur P, Blanchard JM (1985) Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate dehydrogenase multigenic family. Nucleic Acids Res 13:1431-1442[Abstract/Free Full Text].
  • Freedman NJ, Lefkowitz RJ (1996) Desensitization of G-protein-coupled receptors. Recent Prog Horm Res 51:319-351.
  • Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG (1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397-401[Abstract/Free Full Text].
  • Garrett BE, Holtzman SG (1994) D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats. Pharmacol Biochem Behav 47:89-94[Web of Science][Medline].
  • Gerfen CR, Young WS (1988) Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res 460:161-167[Web of Science][Medline].
  • Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ, Sibley Jr DR (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429-1432[Abstract/Free Full Text].
  • Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612[Medline].
  • Greengard P, Allen PB, Nairn AC (1999) Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23:435-447[Web of Science][Medline].
  • Herbert MA, Larson GA, Zahniser NR, Gerhardt GA (1999) Age-related reductions in (3H) WIN35428 binding to the dopamine transporter in nigrostriatal and mesolimbic brain regions of the Fisher 344 rat. J Pharmacol Exp Ther 288:1334-1339[Abstract/Free Full Text].
  • Hersch SM, Ciliax BJ, Gutekunst CA, Rees HD, Heilman CJ, Yung KK, Bolam JP, Ince E, Yi H, Levey AI (1995) Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci 15:5222-5237[Abstract].
  • Herve D, Levi-Strauss M, Marey-Semper I, Verney C, Tassin JP, Glowinski J, Girault JA (1993) G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase. J Neurosci 13:2237-2248[Abstract].
  • Herve D, Rogard M, Levi-Strauss M (1995) Molecular analysis of the multiple Golf alpha subunit mRNAs in the rat brain. Brain Res Mol Brain Res 32:125-134[Medline].
  • Ibanez CF, Ernfors P, Persson H (1991) Developmental and regional expression of choline acetyltransferase mRNA in rat central nervous system. J Neurosci Res 29:163-171[Web of Science][Medline].
  • Jaber M, Robinson SW, Missale C, Caron MG (1996) Dopamine receptors and brain function. Neuropharmacology 35:1503-1519[Web of Science][Medline].
  • Jarvis MF, Williams M (1989) Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective [3H]CGS 21680. Eur J Pharmacol 168:243-246[Web of Science][Medline].
  • Jones DT, Reed RR (1989) Golf: an olfactory neuron specific-G-protein involved in odorant signal transduction. Science 244:790-795[Abstract/Free Full Text].
  • Kawaguchi Y, Wilson CJ, Augood SJ, Emson PC (1995) Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci 18:527-535[Web of Science][Medline].
  • Kemp JM, Powell TP (1971) The structure of the caudate nucleus of the cat: light and electron microscopy. Philos Trans R Soc Lond B Biol Sci 262:383-401[Abstract/Free Full Text].
  • Kull B, Svenningsson P, Fredholm BB (2000) Adenosine A2A receptors are colocalized with and activate Golf in rat striatum. Mol Pharmacol 58:771-777[Abstract/Free Full Text].
  • Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzi T, El Yacoubi M, Vanderhaeghen JJ, Costentin J, Heath JK, Vassart G, Parmentier M (1997) Agressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388:674-678[Medline].
  • Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Böhme GA, Imperato A, Pedrazzini T, Roques BP, Vassart G, Fratta W, Parmentier M (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knock-out mice. Science 283:401-404[Abstract/Free Full Text].
  • Le Moine C, Bloch B (1995) D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J Comp Neurol 355:418-426[Web of Science][Medline].
  • Le Moine C, Normand E, Guitteny AF, Fouque B, Teoule R, Bloch B (1990) Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc Natl Acad Sci USA 87:230-234[Abstract/Free Full Text].
  • Le Moine C, Normand E, Bloch B (1991) Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc Natl Acad Sci USA 88:4205-4209[Abstract/Free Full Text].
  • Levis MJ, Bourne HR (1992) Activation of the alpha subunit of Gs in intact cells alters its abundance, rate of degradation, and membrane avidity. J Cell Biol 119:1297-1307[Abstract/Free Full Text].
  • Marcotte ER, Sullivan RM, Mishra RK (1994) Striatal G-proteins: Effects of unilateral 6-hydroxydopamine lesions. Neurosci Lett 169:195-198[Web of Science][Medline].
  • McKenzie FR, Milligan G (1990) Prostaglandin E1-mediated, cyclic AMP-independent, down-regulation of Gs alpha in neuroblastoma x glioma hybrid cells. J Biol Chem 265:17084-17093[Abstract/Free Full Text].
  • Meyer ME (1993) Effects of intraaccumbens dopamine agonist SK&F38393 and antagonist SCH23390 on locomotor activities in rats. Pharmacol Biochem Behav 45:843-847[Web of Science][Medline].
  • Milligan G (1993) Agonist regulation of cellular G-protein levels and distribution: mechanisms and functional implications. Trends Pharmacol Sci 14:413-418[Medline].
  • Monsma FJ, Mahan LC, McVittie LD, Gerfen CR, Sibley DR (1990) Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc Natl Acad Sci USA 87:6723-6727[Abstract/Free Full Text].
  • Penit-Soria J, Durand C, Besson MJ, Hervé D (1997) Levels of stimulatory G-protein are increased in the rat striatum after neonatal lesion of dopamine neurons. NeuroReport 8:829-833[Web of Science][Medline].
  • Pennartz CM, Groenewegen HJ, Lopes da Silva FH (1994) The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog Neurobiol 42:719-761[Web of Science][Medline].
  • Premont J, Perez M, Bockaert J (1977) Adenosine-sensitive adenylate cyclase in rat striatal homogenates and its relationship to dopamine- and Ca2+-sensitive adenylate cyclases. Mol Pharmacol 13:662-670[Abstract/Free Full Text].
  • Savasta M, Dubois A, Benavides J, Scatton B (1988) Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission. Neurosci Lett 85:119-124[Web of Science][Medline].
  • Schiffmann SN, Jacobs O, Vanderhaeghen J-J (1991) Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not substance P neurons: an in situ hybridization histochemistry study. J Neurochem 57:1062-1067[Web of Science][Medline].
  • Sibley DR, Monsma FJ (1992) Molecular biology of dopamine receptors. Trends Pharmacol Sci 13:61-69[Medline].
  • Sullivan KA, Liao YC, Alborzi A, Beiderman B, Chang FH, Masters SB, Levinson AD, Bourne HR (1986) Inhibitory and stimulatory G-protein of adenylate cyclase: cDNA and amino acid sequences of the alpha  chain. Proc Natl Acad Sci USA 83:6687-6691[Abstract/Free Full Text].
  • Surmeier DJ, Song WJ, Yan Z (1996) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci 16:6579-6591[Abstract/Free Full Text].
  • Svenningsson P, Le Moine C, Kull B, Sunahara R, Bloch B, Fredholm BB (1997) Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience 80:1171-1185[Web of Science][Medline].
  • Svenningsson P, Le Moine C, Fisone G, Fredholm BB (1999) Biochemistry, distribution and function of striatal adenosine A2A receptors. Prog Neurobiol 59:355-396[Web of Science][Medline].
  • Swanson LW (1992) In: Brain maps: structure of the rat brain. Amsterdam: Elsevier.
  • Tassin JP, Trovero F, Herve D, Blanc G, Glowinski J (1992) Biochemical and behavioural consequences of interactions between dopaminergic and noradrenergic systems in rat prefrontal cortex. Neurochem Int [Suppl] 20:225S-230S.
  • Trovero F, Blanc G, Herve D, Vezina P, Glowinski J, Tassin JP (1992) Contribution of an alpha 1-adrenergic receptor subtype to the expression of the "ventral tegmental area syndrome." Neuroscience 47:69-76[Web of Science][Medline].
  • Vezina P, Blanc G, Glowinski J, Tassin JP (1994) Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbens. Synapse 16:104-112[Web of Science][Medline].
  • Xu M, Hu XT, Cooper DC, Moratalla R, Graybiel AM, White FJ, Tonegawa S (1994) Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 79:945-955[Web of Science][Medline].
  • Yan Z, Surmeier DJ (1997) D5 dopamine receptors enhance Zn2+-sensitive GABA(A) currents in striatal cholinergic interneurons through a PKA/PP1 cascade. Neuron 19:1115-1126[Web of Science][Medline].
  • Yoshikawa K, Williams C, Sabol SL (1984) Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system. J Biol Chem 259:14301-14308[Abstract/Free Full Text].
  • Yung KK, Smith AD, Levey AI, Bolam JP (1996) Synaptic connections between spiny neurons of the direct and indirect pathways in the neostriatum of the rat: evidence from dopamine receptor and neuropeptide immunostaining. Eur J Neurosci 8:861-869[Web of Science][Medline].
  • Zahniser NR, Simosky JK, Mayfield RD, Negri CA, Hanania T, Larson GA, Kelly MA, Grandy DK, Rubinstein M, Low MJ, Fredholm BB (2000) Functional uncoupling of adenosine A2A receptors and reduced response to caffeine in mice lacking dopamine D2 receptors. J Neurosci 20:5949-5957[Abstract/Free Full Text].
  • Zhuang X, Belluscio L, Hen R (2000) Golfalpha mediates dopamine D1 receptor signaling. J Neurosci 20:RC91:1-5.


Copyright © 2001 Society for Neuroscience  0270-6474/01/21124390-10$05.00/0


This article has been cited by other articles:


Home page
J. Neurosci.Home page
A. Nishi, M. Kuroiwa, D. B. Miller, J. P. O'Callaghan, H. S. Bateup, T. Shuto, N. Sotogaku, T. Fukuda, N. Heintz, P. Greengard, et al.
Distinct Roles of PDE4 and PDE10A in the Regulation of cAMP/PKA Signaling in the Striatum
J. Neurosci., October 15, 2008; 28(42): 10460 - 10471.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Bertran-Gonzalez, C. Bosch, M. Maroteaux, M. Matamales, D. Herve, E. Valjent, and J.-A. Girault
Opposing Patterns of Signaling Activation in Dopamine D1 and D2 Receptor-Expressing Striatal Neurons in Response to Cocaine and Haloperidol
J. Neurosci., May 28, 2008; 28(22): 5671 - 5685.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A. Plagge, G. Kelsey, and E. L Germain-Lee
Physiological functions of the imprinted Gnas locus and its protein variants G{alpha}s and XL{alpha}s in human and mouse
J. Endocrinol., February 1, 2008; 196(2): 193 - 214.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A.-G. Corbille, E. Valjent, G. Marsicano, C. Ledent, B. Lutz, D. Herve, and J.-A. Girault
Role of Cannabinoid Type 1 Receptors in Locomotor Activity and Striatal Signaling in Response to Psychostimulants
J. Neurosci., June 27, 2007; 27(26): 6937 - 6947.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
N. Wettschureck and S. Offermanns
Mammalian G Proteins and Their Cell Type Specific Functions
Physiol Rev, October 1, 2005; 85(4): 1159 - 1204.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. E. C. Von Dannecker, A. F. Mercadante, and B. Malnic
Ric-8B, an Olfactory Putative GTP Exchange Factor, Amplifies Signal Transduction through the Olfactory-Specific G-Protein G{alpha}olf
J. Neurosci., April 13, 2005; 25(15): 3793 - 3800.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J.-C. Corvol, M.-P. Muriel, E. Valjent, J. Feger, N. Hanoun, J.-A. Girault, E. C. Hirsch, and D. Herve
Persistent Increase in Olfactory Type G-Protein {alpha} Subunit Levels May Underlie D1 Receptor Functional Hypersensitivity in Parkinson Disease
J. Neurosci., August 4, 2004; 24(31): 7007 - 7014.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Lindgren, A. Usiello, M. Goiny, J. Haycock, E. Erbs, P. Greengard, T. Hokfelt, E. Borrelli, and G. Fisone
Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites
PNAS, April 1, 2003; 100(7): 4305 - 4309.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Cai, H.-Y. Wang, and E. Friedman
Increased Dopamine Receptor Signaling and Dopamine Receptor-G Protein Coupling in Denervated Striatum
J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1105 - 1112.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (46)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hervé, D.
Right arrow Articles by Girault, J.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hervé, D.
Right arrow Articles by Girault, J.-A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*AMPHETAMINE
*CAFFEINE
*DOPAMINE

-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-